Current Report Filing (8-k)

Date : 05/07/2019 @ 9:54PM
Source : Edgar (US Regulatory)
Stock : Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
Quote : 57.35  -5.63 (-8.94%) @ 6:53PM

Current Report Filing (8-k)



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 7, 2019 
 
Biohaven Pharmaceutical Holding Company Ltd.
(Exact name of registrant as specified in its charter)
 
British Virgin Islands
 
 

001-38080
 
 

Not applicable
(State or other jurisdiction of
incorporation)
 
 

(Commission File Number)
 
 

(IRS Employer
Identification No.)
c/o Biohaven Pharmaceuticals, Inc.
215 Church Street
New Haven, Connecticut 06510
(Address of principal executive offices, including zip code)
 
(203) 404-0410
(Registrant’s telephone number, including area code)
 
Not applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company o
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o







Item 2.02 Results of Operations and Financial Condition.
 
On May 7, 2019, Biohaven Pharmaceutical Holding Company Ltd. (the “ Registrant ”) issued a press release announcing its financial results for the three months ended March 31, 2019. A copy of this press release is furnished herewith as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
 
In accordance with General Instruction B.2. of Form 8-K, the information in this Item 2.02, and Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Registrant’s filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.


Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits
 
Exhibit Number



Exhibit Description
99.1
 
Press Release, dated May 7, 2019, “Biohaven Pharmaceuticals Reports First Quarter 2019 Financial Results and Advancements in Neuroinnovation Platforms.”







EXHIBIT INDEX
 







SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 

 
 

Biohaven Pharmaceutical Holding Company Ltd.
 
 

 
 

 
 
 

 
 

 
 
 

By:
 

/s/ Vlad Coric, M.D.
Date: May 7, 2019
 
 

Vlad Coric, M.D.
Chief Executive Officer



Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN)
Historical Stock Chart

1 Year : From Jun 2018 to Jun 2019

Click Here for more Biohaven Pharmaceutical Holding Company Ltd. Charts.

Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN)
Intraday Stock Chart

Today : Monday 17 June 2019

Click Here for more Biohaven Pharmaceutical Holding Company Ltd. Charts.

Latest BHVN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.